Literature DB >> 8664301

The interaction of coumarin antibiotics with fragments of DNA gyrase B protein.

N A Gormley1, G Orphanides, A Meyer, P M Cullis, A Maxwell.   

Abstract

DNA gyrase is the target of the coumarin group of antibacterial agents. The drugs are known to inhibit the ATPase activity of gyrase and bind to the 24-kDa N-terminal subdomain of gyrase B protein. Supercoiling assays with intact DNA gyrase and ATPase assays with a 43-kDa N-terminal fragment of the B protein suggest that the drugs bind tightly, with Kd values <10(-7) M. In addition, the ATPase data suggest that 1 coumermycin molecule interacts with 2 molecules of the 43-kDa protein while the other coumarins form a 1:1 complex. This result is confirmed by cross-linking experiments. Rapid gel-filtration experiments show that the binding of ADPNP(5'-adneylyl beta,gamm-imidodiphosphate) and coumarins to the 43-kDa protein is mutally exclusive, consistent with a competitive mode of action for the drugs. Rapid gel-filtration binding experiments using both the 24-and 43-kDa proteins also show that the drugs bind with association rate constants of >10(5) M-1.s-1, and dissociation rate constants of approximately 3x10(-3)s-1 and approximately 4x10(-3)s-1 for the 43-and 24-kDa proteins, respectively. Titration calorimetry shows that the Kd values for coumarins binding to both proteins are approximately 10-8M and that binding is enthalpy driven.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8664301     DOI: 10.1021/bi952888n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  25 in total

1.  Mass spectrometric characterization of a three-enzyme tandem reaction for assembly and modification of the novobiocin skeleton.

Authors:  Na Pi; Caren L Freel Meyers; Michelle Pacholec; Christopher T Walsh; Julie A Leary
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-24       Impact factor: 11.205

2.  Molecular cloning of apicoplast-targeted Plasmodium falciparum DNA gyrase genes: unique intrinsic ATPase activity and ATP-independent dimerization of PfGyrB subunit.

Authors:  Mohd Ashraf Dar; Atul Sharma; Neelima Mondal; Suman Kumar Dhar
Journal:  Eukaryot Cell       Date:  2007-01-12

3.  DNA gyrase can cleave short DNA fragments in the presence of quinolone drugs.

Authors:  M E Cove; A P Tingey; A Maxwell
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

4.  Probing the role of the ATP-operated clamp in the strand-passage reaction of DNA gyrase.

Authors:  A P Tingey; A Maxwell
Journal:  Nucleic Acids Res       Date:  1996-12-15       Impact factor: 16.971

5.  Identification of an auxiliary druggable pocket in the DNA gyrase ATPase domain using fragment probes.

Authors:  Xiaojie Huang; Junsong Guo; Qi Liu; Qiong Gu; Jun Xu; Huihao Zhou
Journal:  Medchemcomm       Date:  2018-07-04       Impact factor: 3.597

6.  IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways.

Authors:  A M O'Farrell; Y Liu; K W Moore; A L Mui
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

7.  Gene expression changes triggered by exposure of Haemophilus influenzae to novobiocin or ciprofloxacin: combined transcription and translation analysis.

Authors:  H Gmuender; K Kuratli; C P Gray; W Keck; S Evers
Journal:  Genome Res       Date:  2001-01       Impact factor: 9.043

8.  Thermodynamic computational approach to capture molecular recognition in the binding of different inhibitors to the DNA gyrase B subunit from Escherichia coli.

Authors:  Liane Saíz-Urra; Miguel Ángel Cabrera Pérez; Matheus Froeyen
Journal:  J Mol Model       Date:  2013-04-30       Impact factor: 1.810

9.  Modulation of gyrase-mediated DNA cleavage and cell killing by ATP.

Authors:  T K Li; L F Liu
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

Review 10.  Strategies for protein synthetic biology.

Authors:  Raik Grünberg; Luis Serrano
Journal:  Nucleic Acids Res       Date:  2010-04-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.